SELUTION4SFA Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.
Also called NCT05132361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Registry
-
NCT05132361
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Austria, Germany, Hong Kong SAR China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05132361. Randomized; single masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2026-07-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SELUTION4SFA Trial
- Condition
- Peripheral Arterial Disease
- Condition
- Superficial Femoral Artery Stenosis
- Intervention (Device)
- SELUTION SLR™ 018 DEB
- Intervention (Device)
- Plain (Uncoated) Balloon Angioplasty (PTA)
- Lead sponsor
- M.A. Med Alliance S.A.
- Collaborator
- NAMSA
- Collaborator
- Cordis US Corp.
Record details
- Record id
cardio:ct-nct05132361- Content hash
a2125487d77a4224cb9a2d564c142a827c9dbfb0a3df0e0a636397d1a71be40b